News & Insights

The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of Complementary Diagnostics

#image_title

An Analysis of NICE Technology Appraisal Decisions ‘Recommended in Line with Clinical Practice’

Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)

$Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL) report cover$

Latest Research & Publications

The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of Complementary Diagnostics

An Analysis of NICE Technology Appraisal Decisions ‘Recommended in Line with Clinical Practice’

Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)

Extrapolation from Progression-Free Survival to Overall Survival in Oncology

Important Aspects of Health Not Captured by EQ-5D: Views of the UK General Public

Uncertainty and Risk in HTA Decision Making

The Distribution of the EQ-5D-5L Index in Patient Populations

Improving Efficiency and Resource Allocation in Future Cancer Care

All Publications

OHE Newsroom

Applications open for MSc Fellowship Programme 2025

A switch to vegan diets could save the NHS £6.7 billion per year, new research reveals

Filter results by

OHE Lunchtime Seminar and Webinar with Professor David Grabowski: Interventions that Encourage High-Value Nursing Home Care: Lessons for the UK

EQ-5D and the EuroQol Group: Past, Present and Future

Important Variations in Access to Orphan Drugs in France, Italy, Germany, Spain and the UK

New Publication: Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value

New Member of the EuroQol Group: OHE’s Dr Yan Feng

New Seminar Briefing: Delivering an Outcomes-based NHS: Creating the Right Conditions

Educational Webinar: Multiple Criteria Decision Analysis for Health Care Decision Making – Emerging Good Practices

Vale Kenneth Arrow! Tony Culyer Writes on the Contributions of the Greatest Economist of Our Time and the Intellectual Father of Health Economics

Does a Biomedical Research Centre Affect Patient Care in Local Hospitals?

New OHE Consulting Report: Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?

OHE is Pleased to Announce the Appointment of Two New Economists: Margherita Neri and Jimena Ferraro

How Should We Choose the Measure of ‘Average’ Preferences?

Subscribe To Our Newsletter

Share on Mastodon